Kris takes LDN for Chronic Lyme pain (Low-dose Naltrexone) from LDN Research Trust on Vimeo.

The Benefits of Low Dose Naltrexone

JewishLink
21 May 2020
https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone

Cory Tichauer, ND - LDN and Lyme Disease I  (2017 Conference) (LDN, low dose naltrexone)

Dr Cory Tichauer shares his presentation on LDN and Lyme Disease at The LDN 2017 Conference.

Dr Tichauer begins by highlighting that Chronic Lyme Disease has many overlapping symptoms from PTLS but can also involve other organ dysfunction due to active infections still causing tissue damage.

Armin Schwarzbach, MD, PhD - Modern tests for diagnosing Lyme Disease (2017 Conference) (LDN, low dose naltrexone)

Lyme disease is a bacterial infection that can be spread to humans by infected ticks. It's usually easier to treat if it's diagnosed early. In this presentation Dr Schwarzbach talks about modern tests for Lyme disease and how crucial it is to get the diagnosis right.

Darin Ingels, ND - Lyme Disease (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Ingels adopts a scientific approach of explaining Lyme Disease, thus the audience can thoroughly understand why specific approaches and treatments work and others do not.

It is commonly misdiagnosed or not diagnosed at all. Lyme disease testing is inadequate and false negative tests are commonplace.

Leonard Weinstock, MD - POTS and Mast Cell Activation Syndromes (2017 Conference) (LDN, low dose naltrexone)

Dr Leonard Weinstock is from St Louis in Missouri and helps patients with GI Issues and other autoimmune conditions.

Kent Holtorf, MD - Immune Dysfunction and Chronic Lyme Disease (2017 Conference) (LDN, low

Dr Kent Holtorf deals specifically with Lyme Disease in this presentation and its impact upon the immune system, explaining the process he uses to test for and diagnose Lyme. 

Kent Holtorf, MD - Immune Modulatory Treatments for Chronic Illness (2018 Conference) (LDN, low dose naltrexone)

Armin Schwarzbach, PhD, MD - Modern diagnostic tests for chronic Lyme disease and coinfections (2018 Conference) (LDN, low dose naltrexone)

Paul Anderson, NMD - Case Studies (2017 Conference) (LDN, low dose naltrexone)

The first case is an oncology patient, a 47 year old female with colorectal cancer.  This lady presented herself while halfway through standard cancer treatment.  Dr Anderson added many adjunct therapies as well as Low Dose Naltrexone and the patients tumour markers reduced for the first time.